Plantable Health Inc.
PLBL.NE
CBOE CA0.02
CAD
+0.01
- -
Plantable Health Inc.
PLBL.NE
(CBOE CA)
Recent
price
0.02
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Plantable Health Inc. (NEO: PLBL), formerly known as Plantable Health Inc. before a name change in July 2024 to Altus Copper Corp., produces and sells plant-based meal products in the United States within the packaged foods industry; it offers the Reboot program, combining 12 meal boxes, one-on-one coaching, and access to the Plantable App; the Quickstart program, a one-week offering including 12 meal boxes, an onboarding call with a coach, and personalized support for up to 14 days; meals-only products; the 3-Day Cleanse, a three-day anti-inflammatory and immunity-boosting program with breakfast, lunch, dinner, and snacks; and à la carte boxes allowing customers to select from 12 fully prepared meals. The company, founded prior to its 2022 IPO listing on the NEO exchange, is headquartered in Vancouver, Canada, and primarily targets consumers seeking clinically supported dietary interventions to reverse and prevent chronic diseases through plant-based nutrition, behavioral science, and digital health tools including coaching and a lifestyle app. Recent developments include a strategic review of alternatives such as potential sale or asset disposition announced in January 2023; board changes in March 2023 appointing directors including Michael Townsend, Geoff Balderson, Arndt Roehlig, and Kevan Matheson; expansion of production volumes under a distribution partnership with CookUnity initiated in October 2022 and updated in January 2023 to meet strong East Coast demand with plans for U.S.-wide growth; selection as meal production and delivery partner for Pivio Health, a Lifestyle Medicine Institute program, in December 2022; launch of the NUTRIVENTION-3 clinical trial at Memorial Sloan Kettering Cancer Center in October 2022; and preliminary positive results from the NUTRIVENTION myeloma cancer trial presented at the 19th International Myeloma Society Annual Meeting in October 2022.